Cellular effector mechanisms against Plasmodium liver stages.
Advances in our understanding of the molecular and cell biology of the malaria parasite have led to new vaccine development efforts resulting in a pipeline of over 40 candidates undergoing clinical phase I-III trials. Vaccine-induced CD4+ and CD8+ T cells specific for pre-erythrocytic stage antigens have been found to express cytolytic and multi-cytokine effector functions that support a key role for these T cells within the hepatic environment. However, little is known of the cellular interactions that occur during the effector phase in which the intracellular hepatic stage of the parasite is targeted and destroyed. This review focuses on cell biological aspects of the interaction between malaria-specific effector cells and the various antigen-presenting cells that are known to exist within the liver, including hepatocytes, dendritic cells, Kupffer cells, stellate cells and sinusoidal endothelia. Considering the unique immune properties of the liver, it is conceivable that these different hepatic antigen-presenting cells fulfil distinct but complementary roles during the effector phase against Plasmodium liver stages.
Frevert
Ute
U
Department of Medical Parasitology, New York University School of Medicine, 341 E 25 St, New York, NY 10010, USA. ute.frevert@nyumc.org
Nardin
Elizabeth
E
D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology*; D006801:Humans; D008099:Liver / Q000276:immunology* / Q000469:parasitology*; D010961:Plasmodium / Q000276:immunology* / Q000502:physiology*; D013601:T-Lymphocytes / Q000276:immunology*